MND drug Qalsody listed on PBS, slashing cost from $28,600 to $25
Australians living with motor neurone disease (MND) will now have cheaper access to treatment through the Pharmaceutical Benefits…
Shared protein pathology redefines treatment for multiple neurodegenerative diseases
On the surface, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and limbic-predominant age-related TDP-43 encephalopathy (LATE) might seem…
New blood protein biomarkers estimate timing of ALS symptoms
Months to several years before amyotrophic lateral sclerosis (ALS) symptoms arise, levels of certain blood proteins may dramatically…
XL20 Crosses Blood-Brain Barrier to Shield ALS Neurons
Summary: Researchers have engineered an experimental small-molecule drug named XL20. Rather than attempting to clumsily clear large cellular…
Experimental drug shields nerve cells from damage caused by ALS
Amyotrophic Lateral Sclerosis, or ALS, received widespread awareness in the summer of 2014 thanks to an Ice Bucket…
A new global collaboration to expand patient-derived stem cell models and accelerate treatments
A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery – current…
Physical Activity and Early Rising Linked to Lower ALS Risk
Summary: Being an “early bird” and maintaining a physically active lifestyle may significantly reduce the risk of developing…
Novel lipid bubble delivery shows promise for ALS treatment
A researcher at the University of Missouri has made a promising breakthrough in the quest to help people…
Morning chronotype and exercise associated with reduced ALS risk
Being an early bird, also called a morning person, and being more physically active are associated with lower…
Restoring protein production in motor neuron axons
Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein…
Exploring the gut-brain-immune axis in neurodegeneration
Neurodegenerative diseases (NDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis…
Neuralink’s breakthrough lets patient control robot with thoughts
Neuralink has claimed to have achieved a new milestone in brain-computer interface technology, with an amyotrophic lateral sclerosis…